Duchenne's Muscular Dystrophy (DMD) Recruiting Phase 1 / 2 Trials for Canakinumab (DB06168)

Also known as: Duchenne's Muscular Dystrophy / Duchenne Muscular Dystrophy (DMD) / Duchenne Muscular Dystrophy / Muscular Dystrophy, Duchenne / Muscular dystrophy

IndicationStatusPhase
DBCOND0066749 (Duchenne's Muscular Dystrophy (DMD))Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03936894Single Escalating Dose Pilot Trial of Canakinumab (ILARISĀ®) in Duchenne Muscular DystrophyTreatment